Return to article
Коррекция сдвига пула желчных кислот у вьюнов с экспериментальными гепатопатиями сульфолитохолевой кислотой
Bile acid pool of loach blood serum after 35 days of pharmacocorrection
µmol/L, M ± SD; * — p < 0.05 compared with the control; # — p < 0.05 compared with the corresponding untreated group
Group | TBA | CA | CDCA | DCA | CA/CDCA |
Control | 5.1 ± 0.9 | 2.6 ± 0.4 | 1.7 ± 0.3 | 0.5 ± 0.1 | 1.53 |
HS (without correction) | 13.7 ± 1.8* | 4.5 ± 0.7* | 5.9 ± 0.9* | 2.9 ± 0.6* | 0.76* |
HS+SLCA-200 | 9.2 ± 1.2*# | 3.6 ± 0.5*# | 3.8 ± 0.6*# | 1.5 ± 0.4*# | 0.95# |
HS+SLCA-400 | 7.4 ± 1.0# | 3.3 ± 0.5# | 2.9 ± 0.5# | 1.0 ± 0.3# | 1.14# |
TH (without correction) | 20.6 ± 2.4* | 5.6 ± 0.8* | 9.4 ± 1.2* | 5.1 ± 0.9* | 0.60* |
TH+SLCA-200 | 12.4 ± 1.6*# | 4.4 ± 0.6*# | 5.1 ± 0.8*# | 2.2 ± 0.5*# | 0.86# |
TH+SLCA-400 | 9.8 ± 1.3# | 4.0 ± 0.6# | 3.9 ± 0.6# | 1.6 ± 0.4# | 1.03# |
